Episode 5: Therapeutic Human Monoclonal Antibodies from SARS-CoV-2 Surface Protein - Creative Biolabs

Échec de l'ajout au panier.

Veuillez réessayer plus tard

Échec de l'ajout à la liste d'envies.

Veuillez réessayer plus tard

Échec de la suppression de la liste d’envies.

Veuillez réessayer plus tard

Échec du suivi du balado

Ne plus suivre le balado a échoué

Episode 5: Therapeutic Human Monoclonal Antibodies from SARS-CoV-2 Surface Protein - Creative Biolabs

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

Monoclonal antibodies are the most important type of biotechnological products after vaccines and recombinant proteins. They are the strategic commanding heights of biotechnology and biomedicine industries in the 21st century. After 35 years of development, monoclonal antibody technology has gone through four stages: murine, chimeric, humanized, and fully human monoclonal antibodies. In response to the COVID-19 outbreak, Creative Biolabs can provide the service of immunizing humanized antibody mice with SARS-CoV-2 surface protein to screen for therapeutic human monoclonal antibodies.

Pas encore de commentaire